The core activity of RegenLab is the development and distribution of medical devices for the production of platelet-rich plasma (PRP) and plasma-related products, particularly in combination with hyaluronic acid or for the production of a biological scaffold. These products are used for various medical applications such as wound management, orthopedics, sports medicine, dermatology, and other areas.
AI-generated
Offering
Products & services
Industry:Medical Technology Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Medical devices for the preparation of RegenPRP™, PRP-HA, autologous thrombin serum, and bone marrow aspirate concentrate for regenerative applications in human medicine.
Knee osteoarthritis treatment
Injection therapies for knee osteoarthritis with Cellular Matrix, RegenPRP™ and hyaluronic acid; explained for patients, including information on mechanism of action, risks, and doctor contact.
RegenPRP™ preparation products
Regen BCT and related systems for the standardized production of leukocyte-reduced, platelet-rich plasma from autologous blood.
PRP-HA preparation products
Cellular Matrix ACP-HA and Cellular Matrix BCT-HA for combining RegenPRP™ or Regen PRP® with hyaluronic acid.
Autologous thrombin serum preparation products
RegenATS™ for physiological platelet activation and for the use of RegenPRP™ as an autologous fibrin glue or in combination with minced tissue.
Knowledge
No knowledge articles yet
Once REGEN LAB SA has claimed this profile, we'll publish editorial articles and case studies here together.